Lucintel Forecasts Global Mrd Testing Market to Reach $4.4 billionby 2030.
Lucintel Forecasts Global Mrd Testing Market to Reach $4.4 billionby 2030.
Stay updated with breaking news from Mrd Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lucintel Forecasts Global Mrd Testing Market to Reach $4.4 billionby 2030.
Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing: Global Markets and Technologies" report has been added to ...
Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "MRD Testing Market - Global and Regional Analysis: Focus on Technology, Target Detection, End User and...
Expert Amir Fathi, MD, reviews recent clinical data with ziftomenib in patients with relapsed/refractory acute myeloid leukemia.
Continuing their discussion on adjuvant therapy in in muscle-invasive bladder cancer, panelists identify the utility of minimal residual disease testing.